by Lexplosion Solution | Feb 19, 2022 | Central, Drugs and medicine, OPS | 0 comments Health Ministry eases norms for manufacture and stocking of new drugs (under Phase III clinical trials) for treating Covid-19 and related diseases You need to be logged in to view this content. Please Log In. Not a Member? Join Us Share this: Share Tweet Pin LinkedIn Related Posts:Health Ministry restricts the manufacture, sale or…Health Ministry restricts the manufacture, sale or…Public comments invited by the Health Ministry on…New Drugs and Clinical Trials Rules amended to… centralDrugs and MedicinesOperations Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
